Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dylan C Dean

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reviews|December 4, 2019
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applicationsPichaya Thanindratarn, Dylan C Dean, Scott D Nelson, et al.
Journal of Cancer|January 2, 2020
Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067Shen Shen, Dylan C Dean, Zujiang Yu, et al.
Frontiers in Oncology|December 7, 2020
Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical StudyRan Wei, Dylan C Dean, Pichaya Thanindratarn, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 13, 2020
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcomaRan Wei, Pichaya Thanindratarn, Dylan C Dean, et al.
Cancer Letters|October 22, 2019
Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic applicationRan Wei, Dylan C Dean, Pichaya Thanindratarn, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 19, 2019
Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777Pichaya Thanindratarn, Xiaoyang Li, Dylan C Dean, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancerWenlong Feng, Dylan C Dean, Francis J Hornicek, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 12, 2021
Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2Xiaoyang Li, Dylan C Dean, Al Ferreira, et al.
Therapeutic Advances in Medical Oncology|September 25, 2020
Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcomaXiaoyang Li, Dylan C Dean, Gregory M Cote, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|July 22, 2020
Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic valuePichaya Thanindratarn, Dylan C Dean, Wenlong Feng, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reviews|December 4, 2019
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applicationsPichaya Thanindratarn, Dylan C Dean, Scott D Nelson, et al.
Journal of Cancer|January 2, 2020
Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067Shen Shen, Dylan C Dean, Zujiang Yu, et al.
Frontiers in Oncology|December 7, 2020
Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical StudyRan Wei, Dylan C Dean, Pichaya Thanindratarn, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 13, 2020
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcomaRan Wei, Pichaya Thanindratarn, Dylan C Dean, et al.
Cancer Letters|October 22, 2019
Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic applicationRan Wei, Dylan C Dean, Pichaya Thanindratarn, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 19, 2019
Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777Pichaya Thanindratarn, Xiaoyang Li, Dylan C Dean, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancerWenlong Feng, Dylan C Dean, Francis J Hornicek, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 12, 2021
Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2Xiaoyang Li, Dylan C Dean, Al Ferreira, et al.
Therapeutic Advances in Medical Oncology|September 25, 2020
Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcomaXiaoyang Li, Dylan C Dean, Gregory M Cote, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|July 22, 2020
Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic valuePichaya Thanindratarn, Dylan C Dean, Wenlong Feng, et al.
Pageof 3